Amyloid β-based therapy for Alzheimer's disease: Challenges, successes and future

Y Zhang, H Chen, R Li, K Sterling… - Signal transduction and …, 2023 - nature.com
Amyloid β protein (Aβ) is the main component of neuritic plaques in Alzheimer's disease
(AD), and its accumulation has been considered as the molecular driver of Alzheimer's …

Advances in the development of new biomarkers for Alzheimer's disease

TO Klyucherev, P Olszewski, AA Shalimova… - Translational …, 2022 - Springer
Alzheimer's disease (AD) is a complex, heterogeneous, progressive disease and is the most
common type of neurodegenerative dementia. The prevalence of AD is expected to increase …

[HTML][HTML] Alzheimer's disease pathophysiology in the retina

BP Gaire, Y Koronyo, DT Fuchs, H Shi… - Progress in retinal and …, 2024 - Elsevier
The retina is an emerging CNS target for potential noninvasive diagnosis and tracking of
Alzheimer's disease (AD). Studies have identified the pathological hallmarks of AD …

[HTML][HTML] Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease

Y Koronyo, D Biggs, E Barron, DS Boyer, JA Pearlman… - JCI insight, 2017 - ncbi.nlm.nih.gov
BACKGROUND. Noninvasive detection of Alzheimer's disease (AD) with high specificity and
sensitivity can greatly facilitate identification of at-risk populations for earlier, more effective …

Spectral-domain OCT measurements in Alzheimer's disease: a systematic review and meta-analysis

VTT Chan, Z Sun, S Tang, LJ Chen, A Wong, CC Tham… - Ophthalmology, 2019 - Elsevier
Topic OCT is a noninvasive tool to measure specific retinal layers in the eye. The
relationship of retinal spectral-domain (SD) OCT measurements with Alzheimer's disease …

Hypertensive eye disease

CY Cheung, V Biousse, PA Keane… - Nature Reviews …, 2022 - nature.com
Hypertensive eye disease includes a spectrum of pathological changes, the most well
known being hypertensive retinopathy. Other commonly involved parts of the eye in …

Retinal microvascular and neurodegenerative changes in Alzheimer's disease and mild cognitive impairment compared with control participants

SP Yoon, DS Grewal, AC Thompson, BW Polascik… - Ophthalmology …, 2019 - Elsevier
Purpose Evaluate and compare the retinal microvasculature in the superficial capillary
plexus (SCP) in Alzheimer's disease (AD), mild cognitive impairment (MCI), and cognitively …

Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina

H Shi, Y Koronyo, A Rentsendorj, GC Regis… - Acta …, 2020 - Springer
Pericyte loss and deficient vascular platelet-derived growth factor receptor-β (PDGFRβ)
signaling are prominent features of the blood–brain barrier breakdown described in …

Ocular indicators of Alzheimer's: exploring disease in the retina

NJ Hart, Y Koronyo, KL Black… - Acta neuropathologica, 2016 - Springer
Although historically perceived as a disorder confined to the brain, our understanding of
Alzheimer's disease (AD) has expanded to include extra-cerebral manifestation, with …

Retinal degeneration and Alzheimer's disease: an evolving link

A Ashok, N Singh, S Chaudhary… - International journal of …, 2020 - mdpi.com
Age-related macular degeneration (AMD) and glaucoma are degenerative conditions of the
retina and a significant cause of irreversible blindness in developed countries. Alzheimer's …